tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market
Holding CDT?
Track your performance easily

Conduit Pharmaceuticals (CDT) Income Statement

163 Followers

Conduit Pharmaceuticals Income Statement

Last quarter (Q ), Conduit Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Conduit Pharmaceuticals's net income was $-5.38M. See Conduit Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21
Total Revenue
----
Cost of Revenue
----
Gross Profit
----
Operating Expense
$ 4.59M$ 5.26M$ 3.16M$ 4.38K
Operating Income
$ -10.44M$ -5.26M$ -3.16M$ -4.38K
Net Non Operating Interest Income Expense
$ -536.52K$ 392.00K$ 1.98M$ -100.00K
Other Income Expense
$ 7.73M$ 5.12M$ -1.73M-
Pretax Income
$ -3.35M$ -535.00K$ -4.89M$ -4.38K
Tax Provision
$ -1.45B$ -1.45B$ 374.86K-
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -8.89M$ -535.00K$ -4.89M$ -4.38K
Basic EPS
$ -0.07$ -0.01$ 0.03-
Diluted EPS
$ -0.12$ -0.09$ 0.03-
Basic Average Shares
$ 406.87M$ 66.97M$ 12.56M$ 2.88M
Diluted Average Shares
$ 410.55M$ 67.89M-$ 2.88M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 4.65M$ 5.26M$ 3.16M$ 4.38K
Net Income From Continuing And Discontinued Operation
$ -9.29M$ -535.00K$ -4.89M$ -4.38K
Normalized Income
$ -1.46B$ -1.45B--
Interest Expense
----
EBIT
$ 1.28M$ -113.00K$ -4.89M$ -4.38K
EBITDA
$ 2.14M$ -113.00K$ -4.89M$ -4.38K
Currency in USD

Conduit Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis